This inventor holds 1 USPTO granted patent. Top assignee: The George Washington University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Ajit Kumar - Innovator in Hepatitis C Research
Introduction
Ajit Kumar is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of medical research, particularly in the area of Hepatitis C Virus (HCV) and its associated complications. His work focuses on innovative methods to combat the effects of HCV on liver health.
Latest Patents
Ajit Kumar holds a patent titled "Blocking Hepatitis C Virus infection associated liver tumor development with HCV-specific antisense RNA." This patent teaches antagonists of Hepatitis C Virus derived microRNA, which are useful in methods for treating and protecting against HCV-mediated hepatocellular carcinogenesis. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Ajit Kumar has established himself as a key figure in his field through his research and innovative approaches. His work has the potential to significantly impact the treatment of liver tumors associated with Hepatitis C, providing new avenues for patient care and management.
Collaborations
Ajit Kumar collaborates with Nagarajan Pattabiraman, enhancing the research efforts in their shared field of study. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Ajit Kumar's contributions to Hepatitis C research highlight his dedication to improving health outcomes through innovation. His work continues to inspire advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile